Fredun Pharmaceuticals Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹213.05 crore, reflecting a quarter-on-quarter *(QoQ) increase of 32.39 per cent from ₹160.93 crore. This corresponds to a year-on-year *(YoY) growth of 27.26 per cent.
Operating Profit
Operating Profit stands at ₹28.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.64 per cent from ₹26.34 crore. This corresponds to a year-on-year *(YoY) growth of 67.42 per cent.
PBDT
PBDT stands at ₹14.40 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 8.75 per cent from ₹15.78 crore. This corresponds to a year-on-year *(YoY) growth of 58.24 per cent.
Profit Before Tax
Profit Before Tax stands at ₹11.25 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.64 per cent from ₹14.00 crore. This corresponds to a year-on-year *(YoY) growth of 54.96 per cent.
Net Profit
Net Profit stands at ₹10.78 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.86 per cent from ₹10.48 crore. This represents a 79.67 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Market News
Fredun Pharmaceuticals Ltd Earnings
- YOY
- QOQ
Fredun Pharmaceuticals Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Fredun Pharmaceuticals Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Fredun Pharmaceuticals Ltd Financial Reports
Fredun Pharmaceuticals Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Fredun Pharma | -3.98% | 1.08% | -1.22% | 56.21% | 27.13% | 232.97% |
| Amrutanjan Healt | 0.37% | 0.43% | -2.67% | -2.65% | -15.68% | -23.17% |
| Ind-Swift Labs. | 8.06% | 21.76% | 20.78% | 30.27% | 74.31% | 86.15% |
| Syncom Formul. | -1.66% | -5.38% | 7.18% | 21.95% | -3.78% | -30.32% |
| Jagsonpal Pharma | -2.50% | -3.80% | -5.18% | 18.04% | -6.61% | -13.05% |
| Shukra Pharma. | 0.52% | 3.74% | -4.46% | -29.15% | -24.04% | 119.76% |
| Lincoln Pharma. | -3.24% | -19.38% | -4.65% | -1.70% | 22.15% | 11.44% |
Company Info
Company Information
Chairperson & Joint MD : Daulat N Medhora
Non Executive Director : Nariman B Medhora
Non Executive & Independent Director : Aspi N Raimalwala
Managing Director & CFO : Fredun N Medhora
Non Executive & Independent Director : Rohinton Kanga
Non Executive & Independent Director : Daisy Dsouza
Independent Director : Anshu Agarwal
Independent Director : Sonal Desai